Previous 10 | Next 10 |
RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals New agreement further expands manufacturing capacity for orally-administered opaganib following positive top-line data from its Phase 2 COVID-19 study, progress with the ong...
Gainers: [[RDHL]] +25.6%. [[GOGO]] +18.6%. [[BBBY]] +17.3%. [[RYTM]] +14.6%. [[AKRO]] +13.6%.Losers: [[OPCH]] -16.7%. [[GRTX]] -16.6%. [[TTOO]] -15.3%. [[WMG]] -7.7%. [[FFIV]] -7.5%. For further details see: BBBY, RDHL, TTOO and OPCH among after-hours movers
GI therapy concern RedHill Biopharma Ltd. (RDHL) has launched three commercial assets in the last 12 months. Sales have been hindered by the pandemic, provoking fears of further dilution (justified). With significant upside for Talicia, six clinical candidates, and its recent addi...
RedHill Biopharma Announces Closing of $25 Million Bought Deal Offering PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , Jan. 14, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical compan...
Shares of RedHill Biopharma (NASDAQ: RDHL) were falling 12.5% lower as of 11:32 a.m. EST on Tuesday. The decline came after the specialty biopharmaceutical company announced that it was increasing the size of its previously announced public stock offering. RedHill now plans to offer...
Gainers: Zomedica (ZOM) +36%, IRIDEX (IRIX) +34%, Biomerica (BMRA) +32%, La Jolla Pharmaceutical (LJPC) +29%, Tyme Technologies (TYME) +15%.Losers: Avinger (AVGR) -17%, TransEnterix (TRXC) -16%, PolarityTE (PTE) -14%, ...
Redhill Biopharma (RDHL) upsizes its bought deal offering to $25M, from initial $10M announced yesterday.The company says underwriters have agreed to purchase 3,188,776 ADSs on the firm commitment basis at a price of $7.84/ADS. Additionally, underwriters have been granted an option to purchas...
RedHill Biopharma Increases Previously Announced Bought Deal to $25 Million PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , Jan. 12, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical co...
Bit Digital (BTBT) -19%.TransEnterix (TRXC) -17% on $31.25M registered direct equity offering.Avinger (AVGR) -12%.LM Funding America (LMFA) -12%.GeoVax Labs (GOVX) -10%.Mesoblast (MESO) -10% after presenting heart failure Phase 3 trial results at Investor Healthcare Conference....
Gainers: [[VOXX]] +42.9%. [[IRIX]] +22.0%. [[PXLW]] +11.8%. [[QTRX]] +7.9%. [[GNMK]] +6.9%.Losers: [[RDHL]] -9.4%. [[LINC]] -6.1%. [[LMND]] -5.3%. [[APM]] -3.9%. [[REVG]] -3.6%. For further details see: VOXX, IRIX, RDHL and LINC among after-hours movers
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd. Company Name:
RDHL Stock Symbol:
NASDAQ Market:
Redhill Biopharma Ltd. Website:
RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 22, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biophar...
RedHill Biopharma Terminates License Agreement for Aemcolo® PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 9, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today ...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...